The Anti-TNF-α Antibody Infliximab Inhibits the Expression of Fat-Transporter-Protein FAT/CD36 in a Selective Hepatic-Radiation Mouse Model
Previously, we reported a radiation-induced inflammation triggering fat-accumulation through fatty-acid-translocase/cluster of differentiation protein 36 (FAT/CD36) in rat liver. Furthermore, inhibition of radiation-induced FAT/CD36-expression by anti-tumor necrosis factor-α (anti-TNF-α) (infliximab...
Main Authors: | Gesa Martius, Silke Cameron, Margret Rave-Fränk, Clemens F. Hess, Hendrik A. Wolff, Ihtzaz A. Malik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/3/4682 |
Similar Items
-
Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease
by: Albert Boronat-Toscano, et al.
Published: (2022-09-01) -
Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01) -
Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
by: Jiaying Chen, et al.
Published: (2023-10-01) -
The Role of Non-Selective TNF Inhibitors in Demyelinating Events
by: Line Buch Kristensen, et al.
Published: (2021-01-01) -
Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
by: Bas J. M. Peters, et al.
Published: (2021-02-01)